Mistake 1: Compliance theater instead of clarity
Regulatory constraints on health claims are real, and healthcare-tech companies need to work within them. But there is a difference between required regulatory hedging and general language timidity that goes far beyond legal necessity.
Sites that bury every claim in qualifiers — "our platform may help support certain aspects of workflow efficiency in certain contexts for certain users" — read as evasive to clinical buyers, not cautious. Clinical professionals are trained to evaluate evidence and recognize when language is obscuring rather than illuminating. A website that sounds like it was written entirely by a legal team communicates that the company does not have the confidence to make direct, defensible claims about what it does.
The solution is not to ignore regulatory constraints — it is to make the strongest claims you can within them. "Reduced scheduling errors by 23% in a study of 150 clinics" is compliant, specific, and compelling. "May support certain scheduling improvements in some clinical environments" is compliant but useless.
Mistake 2: Writing for procurement instead of clinicians
The typical healthcare-tech website is written with the CFO and procurement team as the implied reader — ROI language, compliance certifications, integration ecosystem, enterprise feature lists. This is understandable because procurement signs the contract. But procurement does not usually initiate the evaluation.
In most healthcare-tech buying processes, the clinical staff who will use the product are the first evaluators. A nurse manager researching scheduling software, a genomics researcher evaluating a data management platform, a clinical trial coordinator looking at eClinical tools — these are the people who land on your website first, form an initial impression, and decide whether to escalate to IT and procurement or not.
If your website is incomprehensible to the clinical end-user, you lose the evaluation before it starts. The navigation, the hero copy, and the initial problem framing should speak to clinical workflows and clinical problems — not enterprise software value propositions.
Mistake 3: No structured data for AI visibility
Healthcare professionals increasingly use AI search tools — ChatGPT, Perplexity, Google AI Overviews — to research product categories and clinical topics. A genomics company trying to reach lab directors needs to be visible not just in traditional search but in the AI-mediated research those directors are doing.
Most healthcare-tech sites have minimal structured data implementation. No Article schema on blog posts. No FAQPage schema on content that answers common buyer questions. No Organization schema establishing the company's identity and expertise domain. This means AI tools have less machine-readable signal to use when evaluating whether to cite the site as a source.
The implementation is not complex — Article and FAQPage JSON-LD schema can be added to existing pages in a few hours. The payoff, in terms of AI citation probability and rich result eligibility in traditional search, is significant relative to the effort.
Mistake 4: Analytics that create HIPAA exposure
This is the mistake that gets companies into legal trouble, not just technical trouble. Standard GA4 implementations on healthcare-tech sites frequently collect data that constitutes PHI under HIPAA — typically through URL parameters on patient-facing or health-condition-specific pages that contain identifiers or condition information.
The problem is usually not intentional. A developer implemented GA4 following standard instructions, and no one thought to check whether the URL parameters on the patient scheduling page or the condition-specific resource library were passing sensitive information into analytics. By the time someone asks the question, months of potentially PHI-containing data are in a Google Analytics property without a BAA.
The audit is straightforward: review your GA4 page_location data for any URLs containing query parameters on health-related pages. If those parameters contain anything that could be linked to a specific person's health status, you have a problem that needs immediate remediation.
Mistake 5: A site that cannot be updated by the team that owns it
Healthcare-tech companies move fast. Clinical evidence accumulates, regulatory clearances are obtained, product features launch, reference customers are added. A website that requires a developer ticket and a two-week queue to update a study citation or add a case study is a website that falls behind the company's actual capabilities.
The choice of CMS matters here more than in most B2B contexts, because the content update cadence for a healthcare-tech company is high. Clinical teams find new supporting evidence. Regulatory language needs updating when clearances change. New therapeutic areas get added as the product platform expands.
The right CMS choice allows the team that owns the clinical and regulatory content — not just the marketing team — to make updates in a controlled, reviewable way. Whether that is Webflow with Editor mode, a headless CMS with structured content types, or a custom CMS built around your specific workflow, the governing requirement is: the people who know the content should be able to update it without mediation.
Building or rebuilding a healthcare-tech site?
I have built websites and analytics stacks for medical device companies, genomics firms, and digital health startups — and know exactly where these projects go wrong and how to avoid it.
Get a quote